Suchen Sie nach Informationen zu Hauptsitz Von Alexion Pharmaceuticals? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
https://en.wikipedia.org/wiki/Alexion_Pharmaceuticals
https://www.pharmaceutical-technology.com/projects/alexion-pharmaceuticals-headquarters-new-haven/
Alexion Pharmaceuticals is an international biopharmaceutical company currently based in Cheshire, Connecticut. The company is engaged in innovating, developing and commercialising life-transforming therapeutic products for severe and ultra-rare disorders. It employs around 1,700 people across 50 countries worldwide.
Alexion is a global biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders. Announcement The FDA approved our long-acting C5 complement inhibitor for adults with generalized myasthenia gravis.
https://craft.co/alexion-pharmaceuticals
Alexion Pharmaceuticals has 3,082 employees across 24 locations and $6.07 B in annual revenue in FY 2020. See insights on Alexion Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.
https://alexion.com/worldwide/Switzerland
Switzerland. Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with severe and life-threatening rare disorders. Alexion’s EMEA (Europe, Middle East and Africa) regional headquarters is in Zurich, Switzerland.
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Hauptsitz Von Alexion Pharmaceuticals gefunden haben.
